David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
326
PUT
Biogen
BIIB
$32B
| $46.2M | 0.07% |
109,500
-203,000
| -65% | -$80M |
|
327
Boeing
BA
$169B
| $46.1M | 0.07% |
306,930
-417,001
| -58% | -$60.7M |
|
|
CELG
328
PUT
DELISTED
Celgene Corp
CELG
| $46.1M | 0.07% |
399,500
-784,000
| -66% | -$93.7M |
|
329
PPG Industries
PPG
$25.3B
| $45.6M | 0.07% |
404,072
+348,908
| +632% | +$40M |
|
330
Norwegian Cruise Line
NCLH
$7.92B
| $45.4M | 0.07% |
+840,838
| New | +$40.2M |
|
|
AMAG
331
DELISTED
AMAG Pharmaceuticals
AMAG
| $45.4M | 0.07% |
829,790
+258,073
| +45% | +$12.3M |
|
332
Aramark
ARMK
$15.8B
| $45.2M | 0.07% |
1,980,194
+1,138,503
| +135% | +$26.1M |
|
333
Edwards Lifesciences
EW
$51.8B
| $45.1M | 0.07% |
1,899,714
-614,886
| -24% | -$13.8M |
|
|
334
CALL
Biogen
BIIB
$32B
| $45M | 0.07% |
106,600
-80,700
| -43% | -$31.8M |
|
335
PUT
Verizon
VZ
$205B
| $44.8M | 0.07% |
922,100
-125,980
| -12% | -$6.08M |
|
336
Avis
CAR
$5.18B
| $44.7M | 0.07% |
757,249
-58,186
| -7% | -$3.55M |
|
|
SLXP
337
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $44.7M | 0.07% |
258,455
+256,375
| +12,326% | +$37.6M |
|
338
PUT
Pfizer
PFE
$160B
| $44.6M | 0.07% |
1,351,755
+373,854
| +38% | +$11.9M |
|
|
WWAV
339
DELISTED
The WhiteWave Foods Company
WWAV
| $44.3M | 0.07% |
1,000,000
-600,000
| -38% | -$22.9M |
|
340
PUT
CF Industries
CF
$19.6B
| $44.2M | 0.07% |
779,500
-1,006,500
| -56% | -$60M |
|
341
Green Plains
GPRE
$1.14B
| $44.2M | 0.07% |
1,547,552
+265,866
| +21% | +$6.64M |
|
342
CALL
Comcast
CMCSA
$95.3B
| $44M | 0.07% |
1,560,000
-1,848,200
| -54% | -$53.1M |
|
343
PUT
Baidu
BIDU
$31.6B
| $43.8M | 0.07% |
210,400
-157,500
| -43% | -$33.7M |
|
|
344
Pfizer
PFE
$160B
| $43.7M | 0.07% |
1,323,657
-7,290,844
| -85% | -$232M |
|
|
SHLD
345
DELISTED
Sears Holding Corporation
SHLD
| $43.5M | 0.07% |
1,051,999
-110,081
| -9% | -$4M |
|
346
Alcoa
AA
$13.7B
| $43.5M | 0.07% |
1,400,507
+296,840
| +27% | +$10.7M |
|
|
CELG
347
CALL
DELISTED
Celgene Corp
CELG
| $43M | 0.07% |
373,000
-187,700
| -33% | -$22.4M |
|
348
Saic
SAIC
$5.41B
| $42.9M | 0.07% |
835,646
-128,620
| -13% | -$6.73M |
|
349
CALL
Walmart Inc
WMT
$825B
| $42.9M | 0.07% |
1,565,100
+87,900
| +6% | +$2.49M |
|
|
TWTR
350
CALL
DELISTED
Twitter, Inc.
TWTR
| $42.8M | 0.07% |
854,700
+366,400
| +75% | +$16.2M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.